LNC
45
-5
DFS
68
-2
WBA
47
-3
GPC
37
2
PWR
74
5
LYB
41
-2
EQR
54
4
TEL
71
3
VMC
65
2
TRV
58
3
ZTS
47
7
UNH
67
3
AON
60
4
A
41
-3
CMCSA
53
-11
XRX
37
2
EIX
69
7
ALL
50
5
AAPL
45
2
AIV
51
-4
LNC
45
-5
DFS
68
-2
WBA
47
-3
GPC
37
2
PWR
74
5
LYB
41
-2
EQR
54
4
TEL
71
3
VMC
65
2
TRV
58
3
ZTS
47
7
UNH
67
3
AON
60
4
A
41
-3
CMCSA
53
-11
XRX
37
2
EIX
69
7
ALL
50
5
AAPL
45
2
AIV
51
-4
Financhill
Back

Gilead Sciences 10K Form

Buy
63

GILD
Gilead Sciences

Last Price:
96.54
Seasonality Move:
8.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q GILD/Gilead Sciences Quarterly
2024-02-23 10K GILD/Gilead Sciences Annual
2023-11-07 10Q GILD/Gilead Sciences Quarterly
2023-08-04 10Q GILD/Gilead Sciences Quarterly
2023-05-03 10Q GILD/Gilead Sciences Quarterly
2023-02-22 10K GILD/Gilead Sciences Annual

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $27.12B
Cash Flow: $4.54B
Price / Cash Flow: 12.33
Annual Sales: $14.76
Price / Book: 6.54

Profitability

EPS (TTM): 0.09000
Net Income (TTM): $126M
Gross Margin: $20.62B
Return on Equity: 0.64%
Return on Assets: 0.22%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 33 years for GILD is 76.04%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 22.46% of Gross Profit Margin.
  • The Research & Development expenses have been 21.09% of Revenue.
  • The Interest Expense is 16.66% of Operating Income.
  • The Net Earning history of GILD is 20.89% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 19 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.11
Quick Ratio: 0.82

Price-to-Earnings

Trailing P/E Ratio: 21.46
Forward P/E Ratio: 13.01

GILD Technical Analysis vs Fundamental Analysis

Buy
63
Gilead Sciences (GILD) is a Buy

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Buy
    The current Gilead Sciences [GILD] share price is $96.57. The Score for GILD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.